{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:14:23Z","timestamp":1758474863531,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010009","name":"Heilongjiang Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["LBH-Z16149"],"award-info":[{"award-number":["LBH-Z16149"]}],"id":[{"id":"10.13039\/501100010009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Fund of the Second Affiliated Hospital of Harbin Medical University","award":["KYCX2018-18"],"award-info":[{"award-number":["KYCX2018-18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10072-022-05897-0","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T19:04:29Z","timestamp":1642532669000},"page":"3949-3956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Less is not necessarily more: low-dose corticosteroid therapy and long-term prognosis in generalized myasthenia gravis after thymectomy"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4456-5762","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-6024","authenticated-orcid":false,"given":"Fujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"5897_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1212\/WNL.0000000000009294","volume":"94","author":"GS Gronseth","year":"2020","unstructured":"Gronseth GS, Barohn R, Narayanaswami P (2020) Practice advisory: thymectomy for myasthenia gravis (practice parameter update): report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology 94:705\u2013709. https:\/\/doi.org\/10.1212\/WNL.0000000000009294","journal-title":"Neurology"},{"key":"5897_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB et al (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375:511\u2013522. https:\/\/doi.org\/10.1056\/NEJMoa1602489","journal-title":"N Engl J Med"},{"key":"5897_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","volume":"18","author":"GI Wolfe","year":"2019","unstructured":"Wolfe GI, Kaminski HJ, Aban IB et al (2019) Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Lancet Neurol 18:259\u2013268. https:\/\/doi.org\/10.1016\/S1474-4422(18)30392-2","journal-title":"Lancet Neurol"},{"key":"5897_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8:475\u2013490. https:\/\/doi.org\/10.1016\/S1474-4422(09)70063-8","journal-title":"Lancet Neurol"},{"key":"5897_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M et al (2016) International consensus guidance for management of myasthenia gravis: executive summary. Neurology 87:419\u2013425. https:\/\/doi.org\/10.1212\/WNL.0000000000002790","journal-title":"Neurology"},{"key":"5897_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/jnnp-2017-316625","volume":"89","author":"T Imai","year":"2018","unstructured":"Imai T, Utsugisawa K, Murai H et al (2018) Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan. J Neurol Neurosurg Psychiatry 89:513\u2013517. https:\/\/doi.org\/10.1136\/jnnp-2017-316625","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5897_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/wnl.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323. https:\/\/doi.org\/10.1212\/wnl.55.1.16","journal-title":"Neurology"},{"key":"5897_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","volume":"841","author":"RJ Barohn","year":"1998","unstructured":"Barohn RJ, McIntire D, Herbelin L et al (1998) Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci 841:769\u2013772. https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb11015.x","journal-title":"Ann N Y Acad Sci"},{"key":"5897_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","volume":"17","author":"GO Skeie","year":"2010","unstructured":"Skeie GO, Apostolski S, Evoli A et al (2010) Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 17:893\u2013902. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03019.x","journal-title":"Eur J Neurol"},{"key":"5897_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/nyas.13544","volume":"1413","author":"H Murai","year":"2018","unstructured":"Murai H, Utsugisawa K, Nagane Y et al (2018) Rationale for the clinical guidelines for myasthenia gravis in Japan. Ann N Y Acad Sci 1413:35\u201340. https:\/\/doi.org\/10.1111\/nyas.13544","journal-title":"Ann N Y Acad Sci"},{"issue":"5\u20136","key":"5897_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/08916930903518107","volume":"43","author":"DB Sanders","year":"2010","unstructured":"Sanders DB, Evoli A (2010) Immunosuppressive therapies in myasthenia gravis. Autoimmunity 43(5\u20136):428\u2013435. https:\/\/doi.org\/10.3109\/08916930903518107","journal-title":"Autoimmunity"},{"issue":"5","key":"5897_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/ene.12359","volume":"21","author":"E Kerty","year":"2014","unstructured":"Kerty E, Elsais A, Argov Z, Evoli A, Gilhus NE (2014) EFNS\/ENS Guidelines for the treatment of ocular myasthenia. Eur J Neurol 21(5):687\u2013693. https:\/\/doi.org\/10.1111\/ene.12359","journal-title":"Eur J Neurol"},{"issue":"8","key":"5897_CR13","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","volume":"263","author":"N Melzer","year":"2016","unstructured":"Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, Melms A, Tackenberg B, Schalke B, Schneider-Gold C, Zimprich F, Meuth SG, Wiendl H (2016) Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol 263(8):1473\u20131494. https:\/\/doi.org\/10.1007\/s00415-016-8045-z","journal-title":"J Neurol"},{"issue":"6","key":"5897_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10072-019-03746-1","volume":"40","author":"A Evoli","year":"2019","unstructured":"Evoli A, Antonini G, Antozzi C, DiMuzio A, Habetswallner F, Iani C, Inghilleri M, Liguori R, Mantegazza R, Massa R, Pegoraro E, Ricciardi R, Rodolico C (2019) Italian recommendations for the diagnosis and treatment of myasthenia gravis. Neurol Sci 40(6):1111\u20131124. https:\/\/doi.org\/10.1007\/s10072-019-03746-1","journal-title":"Neurol Sci"},{"key":"5897_CR15","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/wnl.50.6.1778","volume":"50","author":"J Palace","year":"1998","unstructured":"Palace J, Newsom-Davis J, Lecky B (1998) A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group Neurology 50:1778\u20131783. https:\/\/doi.org\/10.1212\/wnl.50.6.1778","journal-title":"Myasthenia Gravis Study Group Neurology"},{"key":"5897_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","volume":"12","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE, Skeie GO, Romi F et al (2016) Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nat Rev Neurol 12:259\u2013268. https:\/\/doi.org\/10.1038\/nrneurol.2016.44","journal-title":"Nat Rev Neurol"},{"key":"5897_CR17","doi-asserted-by":"publisher","unstructured":"Sharshar T, Porcher R, Demeret S, Tranchant C, Gueguen A, Eymard B, Nadaj-Pakleza A, Spinazzi M, Grimaldi L, Birnbaum S, Friedman D, Clair B; MYACOR Study Group. Comparison of corticosteroid tapering regimens in myasthenia gravis: a randomized clinical trial. JAMA Neurol. 2021;78(4):426\u2013433. https:\/\/doi.org\/10.1001\/jamaneurol.2020.5407","DOI":"10.1001\/jamaneurol.2020.5407"},{"key":"5897_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.410150316","volume":"15","author":"RM Pascuzzi","year":"1984","unstructured":"Pascuzzi RM, Coslett HB, Johns TR (1984) Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol 15:291\u2013298. https:\/\/doi.org\/10.1002\/ana.410150316","journal-title":"Ann Neurol"},{"key":"5897_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/mus.24213","volume":"50","author":"K Utsugisawa","year":"2014","unstructured":"Utsugisawa K, Suzuki S, Nagane Y et al (2014) Health-related quality-of-life and treatment targets in myasthenia gravis. Muscle Nerve 50:493\u2013500. https:\/\/doi.org\/10.1002\/mus.24213","journal-title":"Muscle Nerve"},{"key":"5897_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jneuroim.2015.10.018","volume":"289","author":"CY Lee","year":"2015","unstructured":"Lee CY, Lam CL, Pang SY et al (2015) Clinical outcome of generalized myasthenia gravis in Hong Kong Chinese. J Neuroimmunol 289:177\u2013181. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.018","journal-title":"J Neuroimmunol"},{"key":"5897_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2147\/NDT.S243519","volume":"16","author":"D Chen","year":"2020","unstructured":"Chen D, Peng Y, Li Z et al (2020) Prognostic Analysis of Thymoma-associated myasthenia gravis (MG) in Chinese patients and its implication of MG management: experiences from a tertiary hospital. Neuropsychiatr Dis Treat 16:959\u2013967. https:\/\/doi.org\/10.2147\/NDT.S243519","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"5897_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/mus.24438","volume":"51","author":"T Imai","year":"2015","unstructured":"Imai T, Suzuki S, Tsuda E, Nagane Y, Murai H, Masuda M, Konno S, Suzuki Y, Nakane S, Fujihara K, Suzuki N, Utsugisawa K (2015) Oral corticosteroid therapy and present disease status in myasthenia gravis. Muscle Nerve 51(5):692\u2013696. https:\/\/doi.org\/10.1002\/mus.24438","journal-title":"Muscle Nerve"},{"key":"5897_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1600-0404.2005.00424.x","volume":"112","author":"CS Huang","year":"2005","unstructured":"Huang CS, Hsu HS, Huang BS et al (2005) Factors influencing the outcome of transsternal thymectomy for myasthenia gravis. Acta Neurol Scand 112:108\u2013114. https:\/\/doi.org\/10.1111\/j.1600-0404.2005.00424.x","journal-title":"Acta Neurol Scand"},{"key":"5897_CR24","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/s0003-4975(02)04083-3","volume":"74","author":"M de Perrot","year":"2002","unstructured":"de Perrot M, Liu J, Bril V et al (2002) Prognostic significance of thymomas in patients with myasthenia gravis. Ann Thorac Surg 74:1658\u20131662. https:\/\/doi.org\/10.1016\/s0003-4975(02)04083-3","journal-title":"Ann Thorac Surg"},{"key":"5897_CR25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1136\/jnnp.2006.109488","volume":"78","author":"N Tsinzerling","year":"2007","unstructured":"Tsinzerling N, Lefvert AK, Matell G et al (2007) Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry 78:1109\u20131112. https:\/\/doi.org\/10.1136\/jnnp.2006.109488","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5897_CR26","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/mus.25205","volume":"54","author":"JB Andersen","year":"2016","unstructured":"Andersen JB, Gilhus NE, Sanders DB (2016) Factors affecting outcome in myasthenia gravis. Muscle Nerve 54:1041\u20131049. https:\/\/doi.org\/10.1002\/mus.25205","journal-title":"Muscle Nerve"},{"key":"5897_CR27","doi-asserted-by":"publisher","first-page":"e1426","DOI":"10.1212\/WNL.0000000000010209","volume":"95","author":"M Tomschik","year":"2020","unstructured":"Tomschik M, Hilger E, Rath J et al (2020) Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis. Neurology 95:e1426\u2013e1436. https:\/\/doi.org\/10.1212\/WNL.0000000000010209","journal-title":"Neurology"},{"key":"5897_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000658-198707000-00013","volume":"206","author":"AE Papatestas","year":"1987","unstructured":"Papatestas AE, Genkins G, Kornfeld P et al (1987) Effects of thymectomy in myasthenia gravis. Ann Surg 206:79\u201388. https:\/\/doi.org\/10.1097\/00000658-198707000-00013","journal-title":"Ann Surg"},{"key":"5897_CR29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/mus.26300","volume":"58","author":"H Kim","year":"2018","unstructured":"Kim H, Lim YM, Lee EJ et al (2018) Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis. Muscle Nerve 58:796\u2013800. https:\/\/doi.org\/10.1002\/mus.26300","journal-title":"Muscle Nerve"},{"key":"5897_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1053\/j.semtcvs.2016.04.002","volume":"28","author":"AJ Kaufman","year":"2016","unstructured":"Kaufman AJ, Palatt J, Sivak M et al (2016) Thymectomy for myasthenia gravis: complete stable remission and associated prognostic factors in over 1000 cases. Semin Thorac Cardiovasc Surg 28:561\u2013568. https:\/\/doi.org\/10.1053\/j.semtcvs.2016.04.002","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"5897_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/ane.12289","volume":"131","author":"S Yu","year":"2015","unstructured":"Yu S, Li F, Chen B et al (2015) Eight-year follow-up of patients with myasthenia gravis after thymectomy. Acta Neurol Scand 131:94\u2013101. https:\/\/doi.org\/10.1111\/ane.12289","journal-title":"Acta Neurol Scand"},{"key":"5897_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jns.2018.10.018","volume":"396","author":"T Kanai","year":"2019","unstructured":"Kanai T, Uzawa A, Kawaguchi N et al (2019) Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis. J Neurol Sci 396:8\u201311. https:\/\/doi.org\/10.1016\/j.jns.2018.10.018","journal-title":"J Neurol Sci"},{"key":"5897_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000313","volume":"1","author":"Y Suzuki","year":"2011","unstructured":"Suzuki Y, Utsugisawa K, Suzuki S et al (2011) Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study. BMJ Open 1:e000313. https:\/\/doi.org\/10.1136\/bmjopen-2011-000313","journal-title":"BMJ Open"},{"issue":"2","key":"5897_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/mus.23398","volume":"46","author":"M Masuda","year":"2012","unstructured":"Masuda M, Utsugisawa K, Suzuki S et al (2012) The MG-QOL15 Japanese version: validation and associations with clinical factors. Muscle Nerve 46(2):166\u2013173. https:\/\/doi.org\/10.1002\/mus.23398","journal-title":"Muscle Nerve"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-05897-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-05897-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-05897-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:46:39Z","timestamp":1653018399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-05897-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5897"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-05897-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of the 2nd affiliated hospital of Harbin Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}